A forgotten cause of chest pain in the United States: a case report on acute rheumatic fever Authors: Jason A. Miller, Robert Kim, Madhavi Kadiyala, Terry Marryshow, Gordon S. Huggins Published: 2026 ABSTRACT BackgroundAcute rheumatic fever (ARF) is an acute, immune-mediated process that occurs following an untreated Group A Streptococcus (GAS) infection that can result in complications, such as valvular heart disease, myocarditis and arrhythmias. ARF is now rare in the United States which can make it difficult recognize. The standard for diagnosing ARF remains the revised Jones criteria, including serologic evidence of GAS infection. Given it is encountered so infrequently in the United States, clinicians may face uncertainty when interpreting serologic studies and pursuing cardiac imaging in suspected cases.Case presentationWe describe a case of a young white man previously diagnosed with recurrent pericarditis who presented to Tufts Medical Center with chest pain and dyspnea. Around the time of presentation, the patient had tested positive for SARS-CoV-2 with concurrent pharyngitis with white tonsillar exudates. Initial workup was notable for elevated troponin T felt to be out of proportion to pericarditis and changes consistent with myocarditis on cardiac MRI. There were no valvular abnormalities detected on echocardiogram or cardiac MRI. It was later revealed that the patient had been experiencing migratory arthralgias, prompting the measurement of antistreptolysin O (ASO) and antideoxyribonuclease B (ADB), which were both elevated. In combination with serologic evidence of a prior GAS infection, a diagnosis of acute rheumatic fever was made as he satisfied one major (myocarditis) and two minor revised Jones criteria (polyarthralgia and elevated CRP). Though COVID-19 myocarditis was considered as the etiology of his presentation, the recurrent nature of his myopericarditis, multiple prior GAS pharyngitis infections, and elevation in GAS serologic markers favor the diagnosis of ARF.ConclusionsOur case report demonstrates the importance of considering ARF, despite its rarity in the United States. As subacute myocarditis can go undiagnosed by echocardiography, we demonstrate that cardiac MRI is an important tool in establishing a diagnosis of myocarditis that is otherwise inconclusive. The serologic markers ASO and ADB should be used in combination to confirm a preceding GAS infection, given their variability from individual to individual. Background Acute rheumatic fever (ARF) is an acute, immune-mediated process that occurs following an untreated Group A Streptococcus (GAS) infection that can result in complications, such as valvular heart disease, myocarditis and arrhythmias. Left untreated, acute rheumatic fever can progress to rheumatic heart disease, which classically manifests years after initial infection as mitral stenosis, heart failure, and various arrhythmias. Due to improved recognition of GAS pharyngitis along with established treatment options, ARF is rare in the United States compared to developing countries. ARF tends to manifest a few weeks following infection with GAS. The standard for diagnosing ARF relies on satisfying some combination of major and minor revised Jones criteria of 2015 along with serologic evidence of preceding GAS infection [1]. Though the classic acute cardiologic finding of ARF is mitral regurgitation, this study outlines a young man who presented with presumed rheumatic myocarditis when considering clinical presentation, past medical history, serologic markers, and cardiac MRI evidence of myocarditis. Echocardiograms, highly sensitive for identifying valvular pathologies, are not as effective in the workup of myocarditis. Few studies to date have demonstrated the utility of cardiac MRI in the setting of focal rheumatic myocarditis [2]. Our case highlights the increased need for incorporating cardiac MRI in any patient with subclinical rheumatic disease and suspected myocardial involvement. In addition, there is a dearth of literature describing the applicability of current serologic markers that are necessary in establishing an antecedent GAS infection. These markers include antistreptolysin O (ASO) and antideoxyribonuclease B (ADB), which are antibodies created in response to specific enzymes produced by the GAS bacteria. Our report discusses the limitations of these markers along with emphasizing the importance of taking a holistic approach in evaluating each patient with suspected acute rheumatic fever. Presentation of case A 25-year-old white man who reported two prior episodes of pericarditis with reported troponin elevation to 10,000 ng/L (first episode being 7 years ago) and normal left heart catheterization was transferred to the cardiology inpatient service at Tufts Medical Center after presenting with similar chest pain, dyspnea, and elevated troponin. The patient was in his usual state of health until about 2 weeks prior to this admission in which he tested positive for SARS-CoV-2 in the context of a sore throat, dry cough, fatigue, and malaise. Physical examination at that time revealed tonsillar erythema with white exudates, although a rapid streptococcal antigen test was negative. The upper respiratory tract infection symptoms resolved without treatment. In addition, the patient was treated with azithromycin for a recent Chlamydial urethritis infection. Though not initially reported, the patient later endorsed knee soreness for the last month. Three days prior to presenting to our hospital, he began experiencing intermittent, dull, substernal and left chest pressure with radiation to both upper extremities. The pain was not worsened by deep inspiration, leaning forward, or lying supine. He also endorsed dyspnea on exertion and a sense of “chest tightness.” These symptoms intensified, prompting him to come to our Emergency Room. On presentation, his oral temperature was 98.3℉, blood pressure 147/102 mm Hg, heart rate 85 beats per minute, respiratory rate 20 breaths per minute, and oxygen saturation 97% on room air. The patient was well-appearing and in no acute distress. Cardiovascular examination revealed a regular rate and rhythm, normal S1 and S2, no murmurs, rubs, gallops, or chest wall tenderness. Pulmonary exam was clear to auscultation in all lung fields with no wheezes, rales, rhonchi, or crackles. No axillary, cervical, or inguinal lymphadenopathy was appreciated, and no skin changes were noted. The neurological exam revealed no focal neurologic deficits. Blood electrolyte levels, complete blood count, and kidney function tests were within normal limits. High sensitivity troponin T assay was elevated at 375 ng/L, trended with a peak of 527 ng/L nearly 20 hours later. D-dimer was 537 ng/mL. CRP was elevated to 8.89 mg/L (nearly two times the upper limit of normal), though ESR was normal at 11 mm/hr. The electrocardiogram (Fig. 1) showed normal sinus rhythm with no significant PR depression, ST-segment or T-wave abnormalities. Two-view chest X-ray demonstrated clear lung fields and a normal cardiac silhouette. In the Emergency Department, a CT-angiogram showed no evidence of pulmonary embolism, normal heart size, and no pericardial effusion. Transthoracic echocardiogram revealed a preserved ejection fraction (60–65%) with normal left ventricular wall thickness and wall motion, and no valvular abnormalities or pericardial effusion.Fig. 1Electrocardiogram at initial hospitalization in the emergency room. Normal sinus rhythm (heart rate 78 beats per minute) with no PR-segment depression and no significant ST-segment or T-wave abnormalities Electrocardiogram at initial hospitalization in the emergency room. Normal sinus rhythm (heart rate 78 beats per minute) with no PR-segment depression and no significant ST-segment or T-wave abnormalities While the patient initially presented with a self-reported history of pericarditis, the chest discomfort description lacked the characteristic features of pleuritic or positional changes prompting consideration of a cardiac MRI to investigate whether myocarditis could better explain the chest pain in the setting of an unusually high troponin. Indeed, the cardiac MRI identified subepicardial late gadolinium enhancement (LGE) at the basal to mid inferior and inferolateral walls and increased T2 signal (edema) that extended beyond the LGE territory into the basal to mid anterior and anterolateral walls (Figs. 2 and 3). Notably, there was no evidence of wall thinning or hypokinesis in the areas of LGE (Fig. 4). Native T1 mapping and extracellular volume quantification were found to be mildly elevated at 31%, indicative of myocardial edema (Fig. 5). The left ventricular cavity size was normal (LVEDVi = 73 ml/m2) with a calculated left ventricular ejection fraction of 60%. The right ventricular cavity size (RVEDVi = 69 ml/m2) was also normal with the right ventricular ejection fraction equaling 52%. The study did not reveal atrial enlargement. The cardiac MRI findings were interpreted to be consistent with a mixed picture of acute and subacute myocarditis superimposed on prior myocarditis changes.Fig. 2Late gadolinium enhancement images. Short axis and 4-chamber images. Subepicardial late gadolinium enhancement at the basal to mid inferior and inferolateral wall (white arrows) with late gadolinium enhancement burden off 14% at 6 SDFig. 3T2-short tau inversion recovery image in short axis. Increased T2 signal is noted in the basal to mid anterior and anterolateral wall (1) compared to remote myocardium (2). T2 signal in the skeletal muscle (3) is lower compared to myocardiumFig. 4Breath-hold cine steady-state free precession image in the left ventricular short axis view of the left ventricle. End-diastolic frame indicating normal left ventricular mass with no areas of thinningFig. 5Parametric T1 map of the myocardium. The native T1 time in the septal region was increased 1110 ms (normal 900 ms–1050 ms). The calculated extracellular volume was at the upper limit of normal at 31% Late gadolinium enhancement images. Short axis and 4-chamber images. Subepicardial late gadolinium enhancement at the basal to mid inferior and inferolateral wall (white arrows) with late gadolinium enhancement burden off 14% at 6 SD T2-short tau inversion recovery image in short axis. Increased T2 signal is noted in the basal to mid anterior and anterolateral wall (1) compared to remote myocardium (2). T2 signal in the skeletal muscle (3) is lower compared to myocardium Breath-hold cine steady-state free precession image in the left ventricular short axis view of the left ventricle. End-diastolic frame indicating normal left ventricular mass with no areas of thinning Parametric T1 map of the myocardium. The native T1 time in the septal region was increased 1110 ms (normal 900 ms–1050 ms). The calculated extracellular volume was at the upper limit of normal at 31% Because our diagnostic work-up ruled out other causes of chest pain and troponin elevation in a young man, including acute coronary syndrome and pulmonary embolism, we settled on the diagnosis of acute-on-chronic myocarditis. He was discharged from the hospital with instructions to take ibuprofen and colchicine 0.6 mg twice daily, with planned outpatient cardiology follow-up. However, the patient returned to Tufts Medical Center 4 days later with worsening chest pain, dyspnea on exertion and an elevated D-dimer of 847 ng/mL. Upon return to the hospital, the patient also endorsed migrating joint pain in the elbows, fingers, and knees over that week. The vital signs, physical exam, chest X-ray, electrocardiogram, and CT–angiogram were unremarkable. However, review of laboratory work requested during his first admission that had become available included antistreptolysin O (ASO) and antideoxyribonuclease B (ADB) antibody titers, which were both elevated at 243.8 IU/mL (reference range up to 200.0 IU/mL) and 128 U/mL (reference range up to 120.0 U/mL), respectively. Repeat ASO at the second admission remained elevated at 228.9 IU/mL, providing evidence of a prior GAS exposure. Additional testing, including throat culture, antinuclear antibody, HIV serology, and tick panel, were negative. Diagnosis and clinical reasoning We maintained a broad initial differential, ranging from rheumatologic disorders, such as systemic lupus erythematosus, to infectious etiologies which remain the leading cause of myocarditis. The patient’s COVID-19 infection that occurred about 2 weeks prior to his index hospitalization made us consider COVID-19 myocarditis, especially given that COVID-19 myocarditis has a higher incidence than non-COVID infectious etiologies in the United States [3]. We acknowledge that the patient’s cardiac MRI findings were not specific for a distinctive etiology of myocarditis. However, on the basis of the cardiac MRI, serological testing and clinical evaluation, our patient satisfied elements of the revised Jones criteria, including one major (myocarditis) and two minor criteria (arthralgias and elevated CRP) [1]. Elevated ASO and ADB antibody titers served as serologic evidence of a GAS immune response, a requirement in making the diagnosis of acute rheumatic fever [1]. The diagnosis of acute rheumatic fever was supported by his history of recurrent streptococcal pharyngitis infections within the last couple of years (tested positive on rapid streptococcal antigen tests in both 2023 and 2024) and similar infections during childhood. In addition, the patient clinically worsened and represented to our hospital (second admission) after initiation with anti-inflammatory treatment for suspected viral myocarditis but derived meaningful clinical improvement at later outpatient follow-up with secondary prophylaxis for acute rheumatic fever. His bouts of myopericarditis with troponin elevation are a result of longstanding colonization with GAS and subsequent formation of antibodies responsive to surface proteins on the GAS capsule, most notably the M protein [4]. We acknowledge uncertainty in the triggering infection for this presentation. Although our patient tested positive for SARS-CoV-2 by reverse transcription polymerase chain reaction (RT-PCR), that result may not have reflected an active infectious process, since the RT-PCR assay can remain positive for weeks to months after infection [5]. The presence of tonsillar exudates prior to hospitalization supports acute streptococcal pharyngitis rather than COVID-19 associated pharyngitis. We acknowledge that his rapid streptococcal antigen test was negative; however, the false negative rate of that test is as high as 14% in adults [6]. In addition, the patient’s elevation in GAS-specific serology and subsequent downtrend at his second admission supports a recent re-colonization with GAS with waning levels thereafter. Regardless of the etiology of his pharyngitis, we suspect this infection ignited a robust, systemic inflammatory response, re-activating the molecular mimicry mechanism of attack against cardiac antigens leading to myocarditis. Via the same process, previous viral infections could explain his past episodes of pericarditis. [7] Importance of cardiac MRI and echocardiogram in diagnosis Cardiac MRI played an integral role in characterizing the tissue and establishing the diagnosis of myocarditis in our patient. As with other case reports of acute rheumatic fever, the characteristic late gadolinium enhancement on MRI was sufficient to identify inflammatory myocardial changes, most notably edema [8, 9]. It must be noted that cardiac MRI did not establish the etiology of acute rheumatic fever, but assisted in diagnosing myocarditis, the major revised Jones criteria satisfied by the patient’s presentation. When carried out within 1–2 weeks of symptom onset, cardiac MRI has a sensitivity greater than 85% in diagnosing myocarditis when using the updated Lake Louise Criteria, which includes T1 mapping, T2 mapping, extracellular volume, and late gadolinium enhancement (parameters used in our workup) [10]. Echocardiography is less sensitive for detecting changes caused by myocarditis compared with cardiac MRI [10]. This case further highlights that cardiac MRI should be utilized in conjunction with echocardiogram in the diagnostic workup of myocarditis. Utility of antistreptolysin O (ASO) and antideoxyriboneuclease B (ADB) antibody titers ASO and ADB titers, in combination with the revised Jones criteria, remain cornerstones for diagnosing acute rheumatic fever, because they help establish an antecedent GAS infection, necessary for the diagnosis. However, ASO and ADB levels vary based on the recency of the GAS infection or exposure. ASO levels tend to increase 1 week after infection, peak after 3–5 weeks, and begin to decrease around 8 weeks, returning to pre-infection levels after 8 months. ADB follows a similar serologic trend with pre-infection levels achieved around 12 months following GAS infection [11]. However, in a pediatric study, 68% and 56% of children with a documented increase in ASO and ADB, respectively, maintained titers above pre-infection levels for more than 1 year [11]. Individually, ASO and ADB titer sensitivities for acute rheumatic fever can range from 56 to 75%, and specificities between 86 and 93%, but when used together, their combined sensitivity and specificity increase to 95.5% and 88.6%, respectively [12]. The titers can be persistently elevated in people chronically colonized with GAS. Therefore, establishing a threshold for diagnosing a recent GAS infection based on serology alone is difficult given variations in individual exposures and endemicity in a given region. In our case, the patient’s ASO and ADB were measured about 3 weeks following his most recent pharyngitis of unknown etiology. With his recurrent GAS infections in the past and chronic colonization status, his ASO and ADB serology create difficulty in their interpretation. Furthermore, the normative values of these titers vary broadly and are impacted by factors, such as methodologic assay, age, geographic region, and more. For example, in children ages 2–12 years in the United States, the upper limit of normal (ULN) for ASO is 240 IU/mL and for ADB is 640 U/mL, while they are lower in adults given the decreased incidence of infection in the adult population [13]. This lack of standardization of normative values reduces the generalizability of these tests. Therefore, medical practitioners should use an individualized approach when evaluating a patient for acute rheumatic fever, taking into account patient characteristics and clinical presentation while using both ASO and ADB to enhance diagnostic certainty. Discussion of management and follow-up Long-term intramuscular benzathine penicillin G (BPG) injections are indicated to prevent GAS pharyngitis and the recurrence of acute rheumatic fever. The 2020 American Heart Association (AHA) guidelines recommend intramuscular BPG for secondary prophylaxis with the goal of preventing recurrent cardiac insults and the development of rheumatic heart disease [14, 15]. This recommendation is contingent on a diagnosis of acute rheumatic fever, rather than the presence of valvular pathology alone. Both randomized controlled trials and prospective studies have demonstrated fewer intercurrent GAS pharyngeal infections when BPG is given for secondary prophylaxis compared with oral penicillin [16]. There is limited clinical trial data to inform the duration of BPG prophylaxis, but the AHA recommends treating every 3–4 weeks for the longer of 10 years or until the age of 21 for those with acute rheumatic fever and resolved carditis [17]. In our case, the patient received a dose of intramuscular BPG the day of discharge of the second hospitalization. Secondary prophylaxis for 10 years with intramuscular BPG 1.2 million units every 3–4 weeks began thereafter. The patient was provided an emergency 30-day course of oral penicillin as a bridge if he was unable to present on time for his scheduled intramuscular injections in the outpatient setting. At outpatient follow-up about 1 month after his initial presentation, the patient’s chest pain and dyspnea had improved along with resolution of his arthralgias. However, the patient was hospitalized once more about 2 months after initial hospitalization with a viral prodrome and jaundice. At that time, he was found to have hepatomegaly, transaminitis and cholestasis on laboratory workup, positive cytomegalovirus IgM, and eventual findings of acute neutrophilic and eosinophilic cholangitis on percutaneous liver biopsy with unknown etiology. Interestingly, the patient’s ASO decreased to 106.5 IU/mL, consistent with what is typically observed around the eighth week following GAS infection. However, ADB did increase to 183 U/mL. At this hospitalization, a presumed diagnosis of penicillin-induced liver injury was made, and, thus, he was switched to azithromycin for secondary prophylaxis. He is continuing to follow up with both cardiology and infectious disease clinician teams for long-term management of his condition. Patient perspective Since my admissions to Tufts Medical Center, the experience has been a balancing act. Starting the penicillin felt like a necessary step to get ahead of the rheumatic fever, and while I did start to notice my chest and joint pain improving, the injections themselves were a reminder of the illness. I dealt with a lingering lump at the injection site and enough soreness that walking was uncomfortable for a few hours afterward, which was frustrating. The situation became more complicated when I developed a drug-induced liver injury (DILI) from the penicillin. This was discouraging to have a complication from the treatment that was supposed to be helping me, but switching to azithromycin provided a seamless transition. Because these antibiotics are mostly preventative, I have difficulty feeling a significant difference day-by-day. However, compared to the acute, scary episodes I had with pericarditis and myocarditis in the past, this process has felt much more controlled. I find relief in the steady improvement in my joints and chest without constantly worrying about another crisis. Conclusion Though rare in the United States, acute rheumatic fever should be suspected and appropriately diagnosed in those with typical clinical findings that satisfy the revised Jones criteria. Due to the recurrent nature of the disease, especially if improperly treated, this condition has the potential for long-term morbidity in the form of rheumatic heart disease, which typically manifests as mitral stenosis predisposing to cardiac arrhythmias and heart failure. Our case report displays multiple key takeaways. While cardiac MRI can play a significant role in characterizing the degree of cardiac involvement in myocarditis, serologic markers are necessary in establishing a diagnosis of acute rheumatic fever. This case highlighted a patient without the typical symptoms of pericarditis who was previously labeled as having recurrent pericarditis, which prompted the consideration of myocarditis as an explanation of a relatively high troponin level and eventually led to the diagnosis of ARF.